Schedule 13D Page 1 of 15
================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D/A
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. 5)*
EVOLVE SOFTWARE, INC.
--------------------------------------------------------------------------------
(Name of Issuer)
COMMON STOCK
--------------------------------------------------------------------------------
(Title of Class of Securities)
30049 P 708
--------------------------------------------------------------------------------
(CUSIP Number)
MARTHA A. CLARKE ADAMSON
SIERRA VENTURES
2884 SAND HILL ROAD
SUITE 100
MENLO PARK, CA 94025
(650) 854-1000
--------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
MARCH 28, 2003
--------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of Sec. 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the
following box. [ ]
Note: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Sec. 240.13d-7(b) for other
parties to whom copies are to be sent.
* The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
================================================================================
Schedule 13D Page 2 of 15
CUSIP No. 30049 P 708
--------------------------------------------------------------------------------
1. Names of Reporting Persons. I.R.S. Identification Nos. of above
Persons (Entities only).
Sierra Ventures VI, L.P., a California Limited Partnership
("Sierra Ventures VI") 94-3259091
--------------------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group (See
Instructions)
(a) [_]
(b) [X]
--------------------------------------------------------------------------------
3. SEC Use Only
--------------------------------------------------------------------------------
4. Source of Funds (See Instructions) N/A
--------------------------------------------------------------------------------
5. Check Box if Disclosure of Legal Proceedings Is Required Pursuant
to Items 2(d) or 2(e) [_]
--------------------------------------------------------------------------------
6. Citizenship or Place of Organization California
--------------------------------------------------------------------------------
Number of 7. Sole Voting Power 0
Shares -----------------------------------------------------------------
Beneficially 8. Shared Voting Power 194,447 (See (1) below)
Owned by -----------------------------------------------------------------
Each 9. Sole Dispositive Power 0
Reporting -----------------------------------------------------------------
Person With 10. Shared Dispositive Power 202,302 (See (2) below)
--------------------------------------------------------------------------------
11. Aggregate Amount Beneficially Owned by Each Reporting Person
202,302 (See (2) below)
--------------------------------------------------------------------------------
12. Check if the Aggregate Amount in Row (11) Excludes Certain
Shares (See Instructions) [_]
--------------------------------------------------------------------------------
13. Percent of Class Represented by Amount in Row (11)
14.8% (See (5) below)
--------------------------------------------------------------------------------
14. Type of Reporting Person (See Instructions)
PN
--------------------------------------------------------------------------------
Schedule 13D Page 3 of 15
CUSIP No. 30049 P 708
--------------------------------------------------------------------------------
1. Names of Reporting Persons. I.R.S. Identification Nos. of above
Persons (Entities only).
SV Associates VI, L.P., a California limited partnership ("SV
Associates VI") 94-3259090
--------------------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group (See
Instructions)
(a) [_]
(b) [X]
--------------------------------------------------------------------------------
3. SEC Use Only
--------------------------------------------------------------------------------
4. Source of Funds (See Instructions) N/A
--------------------------------------------------------------------------------
5. Check Box if Disclosure of Legal Proceedings Is Required Pursuant
to Items 2(d) or 2(e) [_]
--------------------------------------------------------------------------------
6. Citizenship or Place of Organization California
--------------------------------------------------------------------------------
Number of 7. Sole Voting Power 0
Shares -----------------------------------------------------------------
Beneficially 8. Shared Voting Power 194,447 (See (1) below)
Owned by -----------------------------------------------------------------
Each 9. Sole Dispositive Power 0
Reporting -----------------------------------------------------------------
Person With 10. Shared Dispositive Power 202,302 (See (2) below)
--------------------------------------------------------------------------------
11. Aggregate Amount Beneficially Owned by Each Reporting Person
202,302 (See (2) below)
--------------------------------------------------------------------------------
12. Check if the Aggregate Amount in Row (11) Excludes Certain
Shares (See Instructions) [_]
--------------------------------------------------------------------------------
13. Percent of Class Represented by Amount in Row (11)
14.8% (See (5) below)
--------------------------------------------------------------------------------
14. Type of Reporting Person (See Instructions)
PN
--------------------------------------------------------------------------------
Schedule 13D Page 4 of 15
CUSIP No. 30049 P 708
--------------------------------------------------------------------------------
1. Names of Reporting Persons. I.R.S. Identification Nos. of above
Persons (Entities only).
Sierra Ventures VII, L.P., a California limited partnership
("Sierra Ventures VII") 94-3315644
--------------------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group (See
Instructions)
(a) [_]
(b) [X]
--------------------------------------------------------------------------------
3. SEC Use Only
--------------------------------------------------------------------------------
4. Source of Funds (See Instructions) N/A
--------------------------------------------------------------------------------
5. Check Box if Disclosure of Legal Proceedings Is Required Pursuant
to Items 2(d) or 2(e) [_]
--------------------------------------------------------------------------------
6. Citizenship or Place of Organization California
--------------------------------------------------------------------------------
Number of 7. Sole Voting Power 0
Shares -----------------------------------------------------------------
Beneficially 8. Shared Voting Power 87,458 (See (3) below)
Owned by -----------------------------------------------------------------
Each 9. Sole Dispositive Power 0
Reporting -----------------------------------------------------------------
Person With 10. Shared Dispositive Power 90,233 (See (4) below)
--------------------------------------------------------------------------------
11. Aggregate Amount Beneficially Owned by Each Reporting Person
90,233 (See (4) below)
--------------------------------------------------------------------------------
12. Check if the Aggregate Amount in Row (11) Excludes Certain
Shares (See Instructions) [_]
--------------------------------------------------------------------------------
13. Percent of Class Represented by Amount in Row (11)
7.2% (See (5) below)
--------------------------------------------------------------------------------
14. Type of Reporting Person (See Instructions)
PN
Schedule 13D Page 5 of 15
CUSIP No. 30049 P 708
--------------------------------------------------------------------------------
1. Names of Reporting Persons. I.R.S. Identification Nos. of above
Persons (Entities only).
Sierra Ventures Associates VII, LLC, a California limited
liability company ("SV Associates VII") 94-3315643
--------------------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group (See
Instructions)
(a) [_]
(b) [X]
--------------------------------------------------------------------------------
3. SEC Use Only
--------------------------------------------------------------------------------
4. Source of Funds (See Instructions) N/A
--------------------------------------------------------------------------------
5. Check Box if Disclosure of Legal Proceedings Is Required Pursuant
to Items 2(d) or 2(e) [_]
--------------------------------------------------------------------------------
6. Citizenship or Place of Organization California
--------------------------------------------------------------------------------
Number of 7. Sole Voting Power 0
Shares -----------------------------------------------------------------
Beneficially 8. Shared Voting Power 87,458 (See (3) below)
Owned by -----------------------------------------------------------------
Each 9. Sole Dispositive Power 0
Reporting -----------------------------------------------------------------
Person With 10. Shared Dispositive Power 90,233 (See (4) below)
--------------------------------------------------------------------------------
11. Aggregate Amount Beneficially Owned by Each Reporting Person
90,233 (See (4) below)
--------------------------------------------------------------------------------
12. Check if the Aggregate Amount in Row (11) Excludes Certain
Shares (See Instructions) [_]
--------------------------------------------------------------------------------
13. Percent of Class Represented by Amount in Row (11)
7.2% (See (5) below)
--------------------------------------------------------------------------------
14. Type of Reporting Person (See Instructions)
OO
--------------------------------------------------------------------------------
Schedule 13D Page 6 of 15
(1) Includes all of the shares described in footnote (2) below, but, for
purposes of calculating the voting power, in accordance with the terms of
the Amended and Restated Certificate of Incorporation of Evolve Software,
Inc. (the "Company"), the voting power of shares of Series B Preferred
Stock of the Company ("Series B Preferred Stock") is calculated as if such
shares of Series B Preferred Stock were converted into Common Stock of the
Company ("Common Stock") on the date of the initial issuance of such shares
of Series B Preferred Stock.
(2) Includes 183,960 shares of Common Stock and 18,342 shares of Common Stock
that may be acquired within 60 days by Sierra Ventures VI and SV Associates
VI, respectively, upon conversion of shares of Series B Preferred Stock
held by Sierra Ventures VI and SV Associates VI. All of the numbers of
shares of Common Stock described herein have been adjusted for the 1-for-40
reverse stock split of Common Stock effected on December 19, 2002.
(3) Includes all of the shares described in footnote (4) below, but, for
purposes of calculating the voting power, in accordance with the terms of
the Amended and Restated Certificate of Incorporation of the Company, the
voting power of shares of Series B Preferred Stock is calculated as if such
shares of Series B Preferred Stock were converted into Common Stock on the
date of the initial issuance of such shares of Series B Preferred Stock.
(4) Includes 82,053 shares of Common Stock and 8,180 shares of Common Stock
that may be acquired within 60 days by Sierra Ventures VII and SV
Associates VII, respectively, upon (i) the conversion of shares of Series B
Preferred Stock held by Sierra Ventures VII and SV Associates VII, and (ii)
the exercise of Common Stock Warrants (as defined and further described
under Items 3 and 4 below). All of the numbers of shares of Common Stock
described herein have been adjusted for the 1-for-40 reverse stock split of
Common Stock effected on December 19, 2002.
(5) Based upon 1,165,516 shares of Common Stock outstanding as of February 13,
2003, which is based on the number of shares of Common Stock outstanding as
of such date disclosed in the Company's quarterly report on Form 10-Q for
the fiscal quarter ended December 31, 2002, plus shares of Common Stock
issuable within 60 days to applicable Reporting Persons (as defined below).
Schedule 13D Page 7 of 15
This Amendment No. 5 ("Amendment No. 5") to that certain statement on
Schedule 13D of Sierra Ventures VI, SV Associates VI, Sierra Ventures VII and SV
Associates VII (collectively, the "Reporting Persons") filed October 3, 2001
(the "Original Statement") and amended on October 19, 2001, August 30, 2002,
October 11, 2002 and February 14, 2003 (the "Amended Statement" and together
with the Original Statement, the "Statement") hereby amends and restates the
Statement as provided herein. Capitalized terms used herein and not otherwise
defined shall have the meanings set forth in the Statement. This Amendment No. 5
is being filed to reflect:
(1) The conversion of all shares of Series A Preferred Stock of the
Company held by Sierra Ventures VII and SV Associates VII into an aggregate of
110,450 shares of Common Stock (the "Conversion Shares") on March 28, 2003.
(2) The sale by Sierra Ventures VII and SV Associates VII of
105,000 shares of such Conversion Shares on March 28, 2003.
(3) The sale by Sierra Ventures VII and SV Associates VII of 5,450
shares of such Conversion Shares on March 31, 2003.
The Statement is hereby amended and restated in its entirety as follows:
ITEM 1. SECURITY AND ISSUER
This statement on Schedule 13D relates to the common stock, par value
$0.001 per share (the "Common Stock") of Evolve Software, Inc., a Delaware
corporation (the "Company"). The principal executive offices of the Company are
located at 150 Spear Street, San Francisco, California 94105.
ITEM 2. IDENTITY AND BACKGROUND
(a) This Schedule 13D is being filed on behalf of the Reporting Persons.
The Reporting Persons are making this single, joint filing because
they may be deemed to constitute a "group" within the meaning of
Section 13(d)(3) of the Securities Exchange Act of 1934, as amended
(the "Exchange Act"), although neither the fact of this joint filing
nor anything contained herein shall be deemed an admission by any
Reporting Person that such a "group" exists. The agreement among the
Reporting Persons to file jointly (the "Joint Filing Agreement") was
previously filed as Exhibit 1 to the Statement. Each Reporting Person
disclaims beneficial ownership of all shares of Common Stock, other
than those reported herein as being owned by it.
SV Associates VI and SV Associates VII are the general partners of
Sierra Ventures VI and Sierra Ventures VII, respectively. Management
of the business affairs of SV Associates VI and SV Associates VII,
including decisions respecting disposition and/or voting of the shares
of Common Stock and the exercise of rights to acquire Common Stock, is
by majority decision of the general partners or managing members, as
applicable, of each of SV Associates VI and SV Associates VII,
respectively, as listed on Schedule I hereto. Each individual general
partner and managing member disclaims beneficial ownership of the
shares of Common Stock and rights to acquire such shares, except to
the extent of their pecuniary interest therein.
(b) The address of principal business of each Reporting Person is 2884
Sand Hill Road, Suite 100, Menlo Park, California 94025.
Schedule 13D Page 8 of 15
(c) The principal business of each of the Reporting Persons is that of
making venture capital and similar investments.
(d) None of the Reporting Persons, nor, to the best of their knowledge,
any of the general partners or managing members referred to in
paragraph (a) above has, during the last five years, been convicted in
a criminal proceeding (excluding traffic violations or similar
misdemeanors).
(e) None of the Reporting Persons, nor, to the best of their knowledge,
any of the general partners or managing members referred to in
paragraph (a) above has, during the last five years, been a party to a
civil proceeding of a judicial or administrative body of competent
jurisdiction and as a result of such proceeding was or is subject to a
judgment, decree or final order enjoining future violations of, or
prohibiting or mandating activities subject to, federal or state
securities laws or finding any violation with respect to such laws.
(f) Each of the individuals referred to in paragraph (a) above is a United
States citizen.
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION
Pursuant to the Series A Preferred Stock Purchase Agreement (the "Purchase
Agreement") previously filed as Exhibit 2 to the Statement, dated as of
September 23, 2001, by and between the Company, Sierra Ventures VII, SV
Associates VII and certain other investors named in the Schedule of Purchasers
to the Purchase Agreement, (1) Sierra Ventures VII and SV Associates VII
purchased 90,933 and 9,067 shares, respectively, of the Company's Series A
Preferred Stock (the "Series A Preferred Stock") at a price of $10 per share,
with the purchase price having been paid in cash at the closing of the sale of
such shares on October 9, 2001 (the "Series A Closing"); (2) upon the Series A
Closing, the Company issued to Sierra Ventures VII and SV Associates VII
warrants to purchase up to an aggregate of 90,933 and 9,067 additional shares,
respectively, of Series A Preferred Stock at a price of $10 per share in cash,
which warrants are exercisable for up to one year after the Series A Closing
under certain circumstances, in the forms previously filed as Exhibit 3 to the
Statement ("Preferred Stock Warrants"); (3) upon the Series A Closing, the
Company issued to Sierra Ventures VII and SV Associates VII warrants to purchase
up to 454,665 and 45,335 shares, respectively, of Common Stock at a price of
$1.00 per share in the form previously filed as Exhibit 4 to the Statement
("Common Stock Warrants") and (4) the Company agreed to grant to Sierra Ventures
VII and SV Associates VII additional Common Stock Warrants to purchase that
number of shares of Common Stock equal to 25% of the number of shares of Common
Stock into which the shares of Series A Preferred Stock issued upon exercise of
the Preferred Stock Warrants are convertible at the time such Preferred Stock
Warrants are exercised. Each share of Series A Preferred Stock will be
convertible into Common Stock at a conversion price of $14.80, subject to
certain adjustments as set forth in the Amended and Restated Certificate of
Incorporation of the Company previously filed as Exhibit 14 to the statement
(the "Amended and Restated Certificate").
On March 29, 2002, Sierra Ventures VII and SV Associates VII exercised
warrants to purchase up to 45,467 and 4,533 shares of Series A Preferred Stock,
respectively. Upon exercise of such warrants, the Company issued to Sierra
Ventures VII and SV Associates VII, additional Common Stock Warrants to purchase
up to 227,335 and 22,665 shares of Common Stock, respectively.
The total funds used to purchase the Series A Preferred Stock at the Series
A Closing pursuant to the Purchase Agreement were $909,330 in the case of Sierra
Ventures VII and $90,670 in the case of SV Associates VII and pursuant to the
exercise of warrants to Purchase Series A Preferred Stock on March 29, 2002 were
Schedule 13D Page 9 of 15
$454,670 in the case of Sierra Ventures VII and $45,330 in the case of SV
Associates VII, and were furnished from the working capital of Sierra Ventures
VII and SV Associates VII, respectively. If Sierra Ventures VII and SV
Associates VII elect to exercise the Common Stock Warrants in full for cash, the
total amount of funds that will be required to purchase the Common Stock
pursuant to such warrants will be $682,000 in the case of Sierra Ventures VII
and $68,000 in the case of Sierra Associates VII, which will be provided from
the working capital of Sierra Ventures VII and SV Associates VII, respectively.
However, the Common Stock Warrants provide Sierra Ventures VII and SV Associates
VII the option to convert such warrants on a cashless basis by electing to have
the Company withhold a number of shares otherwise issuable upon exercise of the
Warrants that is equal in value at the time of conversion to the aggregate
exercise price of the shares actually issued upon such conversion. Sierra
Ventures VII and SV Associates VII have not made any determination as to whether
they will exercise the Common Stock Warrants, if at all, either for cash or on a
cashless basis.
Pursuant to the Series B Preferred Stock Purchase Agreement (the "Series B
Purchase Agreement") attached to the Statement as Exhibit 9, dated as of August
20, 2002, by and among the Company, Sierra Ventures VII, SV Associates VII and
certain other investors listed on the signature pages thereto, Sierra Ventures
VII and SV Associates VII purchased 181,866 and 18,134 shares, respectively, of
the Company's Series B Preferred Stock at a price of $10 per share, with the
purchase price having been paid in cash at the closing of the sale of such
shares (the "Series B Closing"). Each share of Series B Preferred Stock will be
convertible into Common Stock at a conversion price of $7.60, subject to certain
adjustments as set forth in the Amended and Restated Certificate.
The total funds used to purchase the Series B Preferred Stock at the Series
B Closing pursuant to the Series B Purchase Agreement were $1,818,660 in the
case of Sierra Ventures VII and $181,340 in the case of SV Associates VII and
were furnished from the working capital of Sierra Ventures VII and SV Associates
VII, respectively.
On September 30, 2002, Sierra Ventures VII sold 134,381 of its shares of
Series B Preferred Stock to Sierra Ventures VI for a cash purchase price of
$1,343,810. Sierra Ventures VII retained ownership of the remaining 47,485
shares of Series B Preferred Stock it purchased at the Series B Closing. In
addition, on September 30, 2002, SV Associates VII sold 13,399 of its shares of
Series B Preferred Stock to SV Associates VI for a cash purchase price of
$133,990. SV Associates VII retained ownership of the remaining 4,735 shares of
Series B Preferred Stock it purchased at the Series B Closing. The funds used
to purchase the foregoing shares of Series B Preferred Stock were furnished from
the working capital of Sierra Ventures VI and SV Associates VI.
On January 29, 2003, Sierra Venture VI, SV Associates VI, Sierra Venture
VII, and SV Associates VII distributed the shares of Common Stock held by them
to their respective limited partners, general partners or members, as
applicable, without consideration, on a pro rata basis pursuant to the terms of
their respective partnership agreements, as amended, or operating agreement, as
amended, as applicable.
On March 28, 2003, Sierra Ventures VII and SV Associates VII elected to
convert all shares of Series A Preferred Stock held by them into an aggregate of
110,450 shares of Common Stock. Sierra Ventures VII and SV Associates VII
subsequently sold 105,000 shares of such Common Stock on March 28, 2003 and the
remaining 5,450 shares of such Common Stock on March 31, 2003.
Schedule 13D Page 10 of 15
ITEM 4. PURPOSE OF TRANSACTION
The Reporting Persons purchased the shares of Series A Preferred Stock and
Series B Preferred Stock held by them and may purchase additional shares of
Common Stock upon exercise of the Common Stock Warrants, in order to obtain an
equity position in the Company for investment purposes.
The Reporting Persons may from time to time acquire shares of Common Stock
or dispose of shares of Common Stock through open market or privately negotiated
transactions, or otherwise, depending on existing market conditions and other
considerations discussed below. Each of the Reporting Persons intends to review
its investment in the Company on a continuing basis and, depending upon the
price and availability of shares of the Company's Common Stock, subsequent
developments affecting the Company, the Company's business and prospects, other
investment and business opportunities available to such Reporting Person,
general stock market and economic conditions, tax considerations and other
factors considered relevant, may decide at any time to increase, or to decrease,
the size of its investment in the Company.
SERIES A PURCHASE AGREEMENT. On September 23, 2001, Sierra Ventures VII
and SV Associates VII entered into the Purchase Agreement pursuant to which the
Company agreed to issue and sell, and Sierra Ventures VII and SV Associates VII
agreed to purchase, shares of Series A Preferred Stock at the Series A Closing
and the Company agreed to issue to Sierra Ventures VII and SV Associates VII the
Preferred Stock Warrants and Common Stock Warrants, all as set forth in Item 3
above. The Common Stock Warrants contain adjustment provisions pursuant to
which, in certain circumstances, Sierra Ventures VII and SV Associates VII may
be entitled to acquire additional shares of Common Stock.
SERIES B PURCHASE AGREEMENT. On August 20, 2002, Sierra Ventures VII and
SV Associates VII entered into the Series B Purchase Agreement pursuant to which
the Company agreed to issue and sell, and Sierra Ventures VII and SV Associates
VII agreed to purchase, shares of Series B Preferred Stock at the Series B
Closing, as set forth in Item 3 above. In addition, the liquidation preference
applicable to the Series B Preferred Stock increases at the rate of 8.00% per
year, compounded quarterly, from the date of issue, and as the number of shares
of Common Stock issuable upon conversion is tied to the liquidation preference,
the number of shares issuable upon conversion of the Series B Preferred Stock
will also increase at a minimum of 8.00% per year, compounded quarterly.
Descriptions of the rights, preferences and privileges of the Series B Preferred
Stock contained herein are qualified in their entirety by reference to the
Amended and Restated Certificate.
CONVERSION OF SERIES B PREFERRED STOCK. Pursuant to the Amended and
Restated Certificate, the Company may cause all of the shares of Series B
Preferred Stock to be automatically converted into Common Stock at any time
after the fifth anniversary of the date of the initial issuance of such shares,
provided that the Company may only cause such automatic conversion if the
closing price per share of Common Stock for 30 consecutive trading days ending
within 10 days of the date on which notice of such automatic conversion is given
to the holders of the Series B Preferred Stock shall have been at least $200.00,
as adjusted for any stock splits, stock dividends and similar events. All shares
of Series B Preferred Stock will also automatically convert into Common Stock at
the election of the holders of a majority of the outstanding shares of Series B
Preferred Stock. The Series B Preferred Stock may also be converted at any time
at the election of each holder.
VOTING. In accordance with the Amended and Restated Certificate, subject
to adjustment for stock dividends, subdivisions, combinations or consolidations,
holders of Series A Preferred Stock shall have one vote for each share of Common
Stock into which the Series A Preferred Stock would have been convertible as of
Schedule 13D Page 11 of 15
October 9, 2001 and holders of Series B Preferred Stock shall have one vote for
each share of Common Stock into which the Series B Preferred Stock would have
been convertible as of date of the initial issuance of Series B Preferred Stock.
The holders of Series A Preferred Stock and Series B Preferred Stock are
entitled to vote on an as converted to Common Stock basis together with the
holders of Common Stock as a single class upon any matter submitted to
stockholders for a vote, except under specified circumstances described under
the sections below entitled "Board Representation" with respect to the election
of directors and under the sections below entitled "Change of Control" with
respect to certain Change of Control Transactions (as defined in the Amended and
Restated Certificate).
The Company will not, without the affirmative vote or written consent of
(a) the holders of not less than a majority of the outstanding shares of Series
A Preferred Stock, voting together as a single class, on an as converted to
Common Stock basis, provided that at least 50% of the shares of Series A
Preferred Stock issued by the Company remain outstanding and (b) the holders of
not less than a majority of the outstanding shares of Series A Preferred Stock
and Series B Preferred stock, voting together as a single class, on an as
converted to Common Stock basis, provided that at least 50% of the shares of
Series B Preferred Stock issued by the Company remain outstanding: (i) amend or
repeal any provision of, or add any provision to, the Amended and Restated
Certificate; (ii) issue any bonds, debentures or notes or incur similar debt
obligations, other than trade debt in the ordinary course of business; (iii)
repurchase any outstanding shares of stock, except for repurchase of shares held
by employees pursuant to repurchase agreements approved by the board of
directors and redemption of shares of Preferred Stock of the Company; or (iv)
amend the bylaws to increase the authorized number of directors of the Company
to more than eight.
In addition, the Company will not without first obtaining the affirmative
vote or written consent of the holders of not less than a majority of the
outstanding shares of Series A Preferred Stock, voting together as a single
class, on an as converted to Common Stock basis, provided that at least 50% of
the shares of Series A Preferred Stock issued by the Company remain outstanding:
(i) pay any dividend on any shares of Series A Junior Stock (as defined in the
Amended and Restated Certificate), or repurchase or redeem any such shares of
Series A Junior Stock except for repurchases of unvested shares of Series A
Junior Stock at cost from employees, directors, consultants and other service
providers; or (ii) authorize or issue any shares of any class or series of
Senior Stock (as defined in the Amended and Restated Certificate), or Series A
Parity Preferred Stock (as defined in the Amended and Restated Certificate) or
any bonds, debentures, notes or other obligations convertible into or
exchangeable for, or having option rights to purchase, any shares of Senior
Stock or Series A Parity Preferred Stock.
Furthermore, the Company will not without first obtaining the affirmative
vote or written consent of the holders of not less than a majority of the
outstanding shares of Series A Preferred Stock and Series B Preferred Stock,
voting together as a single class, on an as converted to Common Stock basis,
provided that at least 50% of the shares of Series B Preferred Stock issued by
the Company remain outstanding: (i) pay any dividend on any shares of Series B
Junior Stock (as defined in the Amended and Restated Certificate), or repurchase
or redeem any such shares of Series B Junior Stock except for repurchases of
unvested shares of Series B Junior Stock at cost from employees, directors,
consultants and other service providers; or (ii) authorize or issue any shares
of any class or series of Senior Stock or Series B Parity Preferred Stock (as
defined in the Amended and Restated Certificate) or any bonds, debentures, notes
or other obligations convertible into or exchangeable for, or having option
rights to purchase, any shares of Senior Stock or Series B Parity Preferred
Stock.
Schedule 13D Page 12 of 15
BOARD REPRESENTATION. Subject to applicable laws or regulations or the
rules of the Nasdaq Stock Market, the holders of Series B Preferred Stock shall
be entitled to elect such number of additional directors which, in addition to
the three directors that the holders of Series A Preferred Stock are entitled to
elect, is in as close a proportion as possible to the total number of directors
of the Company as the proportion of the number of shares of Common Stock
issuable upon the conversion of such shares of Series A Preferred Stock and
Series B Preferred Stock is to the total outstanding shares of Common Stock
(treating all shares of Series A Preferred Stock and Series B Preferred Stock on
an as converted to Common Stock basis).
CHANGE OF CONTROL. Under the Amended and Restated Certificate, the Company
will not, without the affirmative vote or written consent of (a) the holders of
not less than a majority of the outstanding shares of Series A Preferred Stock,
voting together as a single class, on an as converted to Common Stock basis,
provided that at least 50% of the shares of Series A Preferred Stock issued by
the Company remain outstanding, and (b) the holders of not less than a majority
of the outstanding shares of Series A Preferred Stock and Series B Preferred
stock, voting together as a single class, on an as converted to Common Stock
basis, provided that at least 50% of the shares of Series B Preferred Stock
issued by the Company remain outstanding, consummate a Change of Control
Transaction (as defined in the Amended and Restated Certificate), unless the
aggregate value received for, or realizable in respect of, all outstanding
shares of Series A Preferred Stock and Series B Preferred Stock as a result of
such sale or other transaction or series of transactions exceeds an amount equal
to $10.00 per share (as adjusted for stock splits and dividends in kind)
multiplied by the number of outstanding shares of Series A Preferred Stock and
Series B Preferred Stock (the "Aggregate Cash Purchase Price"), plus an amount
sufficient to result in an overall internal rate of return on the Aggregate Cash
Purchase Price of 50%, taking into account for purposes of calculating such
overall internal rate of return any differences in the dates of issuance of such
outstanding shares. In addition, in the event of any Change of Control
Transaction, holders of Common Stock Warrants will have the right to deliver
such warrants to the Company in exchange for payments equal to the Black-Scholes
value of such warrants at the time of such transaction, payable in cash or,
subject to certain conditions, Common Stock of the Company.
REGISTRATION OF SHARES OF COMMON STOCK FOR RESALE. Pursuant to the terms
of the Series B Purchase Agreement and the agreements related thereto, subject
to certain conditions the Company has agreed to prepare and file with the
Securities and Exchange Commission, upon request of holders of Series B
Preferred Stock after June 1, 2002, registration statements to enable the resale
of the shares of Common Stock issued or issuable upon conversion of the Series B
Preferred Stock.
PREEMPTIVE RIGHTS. Subject to certain exceptions, the Company will grant to
the purchasers of Series A Preferred Stock and the purchasers of Series B
Preferred Stock rights to maintain their percentage ownership in the Company in
the event of future equity issuances by the Company. A copy of the form of
Preemptive Rights Agreement and a copy of the form of Series B Preemptive Rights
Agreement providing for such rights were previously filed as Exhibit 6 and
Exhibit 13 to the Statement, respectively.
The foregoing summary of the Purchase Agreement, the Series B Purchase
Agreement and the agreements and transactions contemplated thereby is qualified
in its entirety by reference to the Purchase Agreement, the Common Stock
Warrants, the Preemptive Rights Agreement, the Series B Purchase Agreement, the
Series B Preemptive Rights Agreement and the Amended and Restated Certificate,
which are Exhibits 2, 4, 6, 9, 13 and 14 hereto, respectively, and are
incorporated herein by reference.
Schedule 13D Page 13 of 15
Except as set forth in this Item 4 or in Item 6, none of the Reporting
Persons currently have any plans or proposals that relate to or would result in
any of the actions specified in clauses (a) through (j) of Item 4 of Schedule
13D.
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER
(a) For each of the Reporting Persons, the aggregate number of shares of
Common Stock beneficially owned and the percentage of Common Stock
beneficially owned based upon 1,165,516 shares of Common Stock
outstanding as of February 14, 2003, which is based on the number of
shares of Common Stock outstanding as of such date disclosed in the
Company's quarterly report on Form 10-Q for the fiscal quarter ended
December 31, 2002, is as follows:
Name Shares Beneficially Owned Percentage
----------------------------------- ------------------------- ----------
Sierra Ventures VI, L.P. 202,302 14.8%
SV Associates VI, L.P. 202,302 14.8%
Sierra Ventures VII, L.P. 90,233 7.2%
Sierra Ventures Associates VII, LLC 90,233 7.2%
(b) The number of shares of Common Stock of the Company as to which each
of the Reporting Persons has sole or shared power to vote are as set
forth in rows 7-8 of the cover pages hereof, including the footnotes
thereto.
(c) Other than as set forth in Item 3 hereof, no transactions in the
Common Stock were effected during the last 60 days by the Reporting
Persons or any of the persons set forth on Schedule I hereto.
(d) Except as set forth in this Item 5 and in Item 2(a) hereof, no person
other than each respective record owner referred to herein of
securities is known to have the right to receive or the power to
direct the receipt of dividends from, or the proceeds from the sale
of, such securities.
(e) Not applicable.
ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH
RESPECT TO SECURITIES OF THE ISSUER
Pursuant to Rule 13d-1(k) promulgated under the Exchange Act, the Reporting
Persons have entered into an agreement previously filed as Exhibit 1 to the
Statement, with respect to the joint filing of this statement and any amendment
or amendments hereto.
As an inducement to Warburg Pincus Private Equity VIII, L.P. ("Warburg") to
enter into the Purchase Agreement, on September 23, 2001 the Reporting Persons
and certain other stockholders of the Company (together with the Reporting
Persons, the "Stockholders"), entered into a voting agreement (the "Voting
Agreement") with Warburg in the form previously filed as Exhibit 7 to the
Statement. Pursuant to the Voting Agreement, each of the stockholders agreed to
vote (or cause to be voted) all of the shares of the Company's stock owned or
acquired by them at any meeting of the stockholders of the Company, and in any
Schedule 13D Page 14 of 15
action by written consent of the stockholders of the Company, (i) in favor of
the approval of the transactions contemplated by the Purchase Agreement
including the issuance of capital stock of the Company pursuant thereto, (ii) in
favor, to the extent it is necessary, of an increase in the number of
authorized, but unissued, shares of Common Stock, in an amount determined by the
Company's Board of Directors, (iii) in favor, if proposed by the Company's Board
of Directors, of a reverse stock split of the Common Stock, and (iv) in favor of
any other matter directly relating to and in furtherance of consummation of the
transactions contemplated by the Purchase Agreement. This summary of the Voting
Agreement is qualified in its entirety by reference to the form of Voting
Agreement previously filed as Exhibit 7 to the Statement.
The Purchase Agreement and the Series B Purchase Agreement and the
agreements contemplated thereby are described in Item 3, Item 4 and Item 5
above.
Except as described above, there are no contracts, arrangements,
understandings or relationships (legal or otherwise) among the persons named in
Item 2 above or between the Reporting Persons and any other person with respect
to any securities of the Company.
ITEM 7. MATERIAL TO BE FILED AS EXHIBITS
Exhibit 1. Joint Filing Agreement dated October 2, 2001 among the
Reporting Persons.*
Exhibit 2. Series A Preferred Stock Purchase Agreement, dated as of
September 23, 2001, by and among the Company, the Reporting
Persons and certain other persons.*
Exhibit 3. Form of Form A Subscription Warrant and Form of Form B
Subscription Warrant.*
Exhibit 4. Form of Warrant to Purchase Shares of Common Stock.*
Exhibit 5. Form of Certificate of Designation of Series A Preferred
Stock of Evolve Software, Inc.*
Exhibit 6. Form of Preemptive Rights Agreement between the Company, the
Reporting Persons and certain other persons.*
Exhibit 7. Form of Voting Agreement among Warburg and the Reporting
Persons.*
Exhibit 8. Power of Attorney*
Exhibit 9. Series B Preferred Stock Purchase Agreement, dated as of
August 20, 2002, by and among the Company, the Reporting
Persons and certain other persons.*
Exhibit 10. Certificate of Designation of Series B Preferred Stock of
the Company filed with the Secretary of State of the State
of Delaware on August 20, 2002.*
Exhibit 11. Certificate of Amendment to Certificate of Designation of
Series B Preferred Stock of the Company filed with the
Secretary of State of the State of Delaware on August 20,
2002.*
Schedule 13D Page 15 of 15
Exhibit 12. Certificate of Amendment to Certificate of Designation of
Series B Preferred Stock of the Company filed with the
Secretary of State of the State of Delaware on August 23,
2002.*
Exhibit 13. Form of Series B Preemptive Rights Agreement between the
Company, the Reporting Persons and certain other persons.*
Exhibit 14. Amended and Restated Certificate of Incorporation of the
Company filed with the Secretary of State of the State of
Delaware on December 17, 2002.*
_____________________________
* Previously filed.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this Amendment No. 5 to Schedule 13D
is true, complete and correct.
Dated: April 8, 2003 SIERRA VENTURES VI, L.P.
By: SV Associates VI, L.P.
Its General Partner
By: /s/ Jeffrey M. Drazan
----------------------------
Name: Jeffrey M. Drazan
Title: General Partner
Dated: April 8, 2003 SV ASSOCIATES VI, L.P.
By: /s/ Jeffrey M. Drazan
----------------------------
Name: Jeffrey M. Drazan
Title: General Partner
Dated: April 8, 2003 SIERRA VENTURES VII, L.P.
By: Sierra Ventures Associates VII, LLC
Its General Partner
By: /s/ Jeffrey M. Drazan
----------------------------
Name: Jeffrey M. Drazan
Title: Manager
Dated: April 8, 2003 SIERRA VENTURES ASSOCIATES VII, LLC
By: /s/ Jeffrey M. Drazan
----------------------------
Name: Jeffrey M. Drazan
Title: Manager
SCHEDULE I
GENERAL PARTNERS OF SV ASSOCIATES VI, L.P. AND MANAGING MEMBERS OF SIERRA
VENTURES ASSOCIATES VII, LLC
Set forth below, with respect to each general partner of SV Associates VI,
L.P., and managing member of Sierra Ventures Associates VII, LLC are the
following: (a) name; (b) business address and (c) citizenship.
1. (a) Peter C. Wendell
(b) c/o Sierra Ventures
2884 Sand Hill Road
Suite 100
Menlo Park, CA 94025
(c) United States Citizen
2. (a) Jeffrey M. Drazan
(b) c/o Sierra Ventures
2884 Sand Hill Road
Suite 100
Menlo Park, CA 94025
(c) United States Citizen
3. (a) David C. Schwab
(b) c/o Sierra Ventures
2884 Sand Hill Road
Suite 100
Menlo Park, CA 94025
(c) United States Citizen
4. (a) Steven P. Williams (Managing Member of Sierra Ventures
Associates VII, LLC only)
(b) c/o Sierra Ventures
2884 Sand Hill Road
Suite 100
Menlo Park, CA 94025
(c) United States Citizen